| Start date | Project | acronym | role | funding | partners |
|---|
| 2007-01-01 | Surveillance network of Reoviruses, Bluetongue and African Horse Sickness, in the Mediterranean basin |
MED_REO_NET | participant | 460.000 | 21 |
| 2006-12-01 | Goat BSE: Proposal for improvement of goat TSE discriminative diagnosis and susceptibility based assessment of BSE infectivity in goat milk and meat |
GOATBSE | participant | 3.849.994 | 10 |
| 2006-06-01 | Network on epizootic disease diagnosis and control |
EPIZONE | participant | 14.000.000 | 21 |
| 2006-04-01 | Co-ordination, harmonisation and exchange of biosecurity practices within a pan European network |
BIOSAFETY-EUROPE | participant | 747.137 | 19 |
| 2006-04-01 | Cutting edge genomics for sustainable animal breeding |
SABRE | participant | 13.900.793 | 40 |
| 2005-01-01 | FMD and CSF coordination action |
CA FMD/CSF | coordinator | 1.000.000 | 11 |
| 2004-11-01 | New and emerging technologies: improved laboratory and on-site detection of OIE list A viruses in animals and animal products |
LAB-ON-SITE | participant | 1.500.000 | 9 |
| 2004-10-01 | Development of intervention strategies against sars in a European-Chinese taskforce |
DISSECT | participant | 2.384.892 | 10 |
| 2004-09-01 | European animal disease genomics network of excellence for animal health and food safety |
EADGENE | participant | 11.519.980 | 17 |
| 2004-02-01 | Salmonella-free broilers by live vaccine-induced innate resistance to colonisation and invasion and novel methods to eliminate vaccine and field strains |
SUPASALVAC | coordinator | 2 | 13 |
| 2004-01-01 | Improvement of Foot and Mouth disease control by ehtically acceptable methods based on scientifically validated assays and new knowledge on FMD vaccines, including the impact of vaccination |
FMD_IMPROCON | participant | 2.399.907 | 10 |
| 2003-09-01 | Prevention, control and management of prion diseases |
NEUROPRION | participant | 14.400.000 | 41 |
| 2003-01-01 | European project to study bse strain in sheep |
BSE IN SHEEP | participant | 2.656.845 | 8 |
| 2002-11-01 | Passage from intestine to brain: assessing the role of dendritic cells in capturing, expanding and disseminating prions |
IMMUNOTSE | participant | 1.522.758 | 8 |
| 2002-10-01 | Improved bioassays for tse agents based on the bank vole, a wild rodent species higly susceptible to scrapie |
EUROVOLTE | participant | 799.995 | 6 |
| 2002-10-01 | European network for surveillance and control of tse in small ruminants |
WITH EMPHASIS ON EPI | participant | 1.519.116 | 39 |
| 2002-09-01 | Foot-and-mouth disease virus: the molecular basis of tissue tropism and persistence |
FMD TROPISM | coordinator | 964.062 | 3 |
| 2002-09-01 | Biosage coronavirus vector-based vaccine for prevention of foot-and-mouth disease |
FMDV VACCINE | participant | 1.554.598 | 6 |
| 2002-09-01 | Pathways and mechanisms in the spread of prpsc to the central nervous system |
PRPSC-NEUROPATHWAYS | participant | 1.769.438 | 6 |
| 2002-09-01 | Optimizing dna based vaccination against fmdv in sheep and pigs |
FMDNAVACC | participant | 1.299.687 | 4 |
| 2002-09-01 | Development of a pathogen epitope prediction program, and evaluation of its usefulness in designing fish vaccines |
PEPTIDEX | participant | 1.600.043 | 4 |
| 2002-05-01 | The structure and function of the internal ribosome entry sites from foot-and-mouth disease and encephalomyocarditis virus RNAs |
| coordinator | 60.000 | 4 |
| 2002-01-01 | International conference on transmissible spongiform encephalopathies |
TSE CONFERENCE | coordinator | 69.780 | 1 |
| 2001-12-01 | Development of a safe, efficacious bluetongue virus vaccination strategy for europe (BLUETONGUE VACCINATION) |
BLUETONGUE VACCINATI | coordinator | 1.698.569 | 5 |
| 2001-11-01 | Immunological mechanisms of protection against classical swine fever virus: towards the development of new efficacious marker vaccines |
IMPCSF | participant | 998.114 | 4 |
| 2001-11-01 | African swine fever : improved diagnostic methods and understanding of virus epidemiology and virus-host interactions (ASF CONTROL) |
ASF CONTROL | participant | 1.467.035 | 8 |
| 2001-04-01 | Stable transformation for the study of secretory organelles in eimeria |
| coordinator | 114.272 | 1 |
| 2001-02-01 | Evaluation of the inactivation / removal effect of the gelatin manufacturing process on tse infectivity |
GELATIN PROCESS | participant | 277.589 | 3 |
| 2001-01-01 | Phylogenetic sequence analysis and improved diagnostic assay systems for viruses of the family reoviridae |
REO ID | coordinator | 1.216.087 | 5 |
| 2000-12-01 | Microarray analysis of gene function and host interaction in salmonella typhimurium |
SALARRAY | coordinator | 1.399.415 | 7 |
| 2000-12-01 | Bluetongue & other culicoides-bornes diseases threatening the eu : identification of vulnerable areas by surveillance & gis modelling to aid risk assessment |
ARBOVIRUS VECTORS & | coordinator | 1.099.969 | 11 |
| 2000-12-01 | Implications of the introduction of automatic milking on dairy farms |
AUTOMATIC MILKING | participant | 2.420.001 | 9 |
| 2000-11-01 | The potential and application of virus host evasion genes that modify apoptosis and cytokine responses |
APOPTOSIS & CYTOKINE | participant | 1.082.314 | 4 |
| 2000-10-01 | Control of rinderpest (rp) and peste des petits ruminants (ppr) infections: development of oral vaccine, role of wildlife in the maintenance of these diseases |
RP/PPR ORALVAC | participant | 880.004 | 6 |
| 2000-10-01 | Attaching and effacing escherichia coli infections : pathogenesis, host response and epidemiology. |
AEEC INFECTIONS | participant | 1.770.702 | 10 |
| 2000-02-01 | Generic coronavirus vaccine vectors for protection of farm animals against mucosal infections |
CORONAVIRUS VECTORS | coordinator | 917.349 | 4 |
| 2000-02-01 | Reverse genetics of respiratory syncytial virus: generation of attenuated vaccine candidates |
RSV VAC | participant | 1.653.873 | 5 |
| 2000-02-01 | Chicken image : improvement of chicken immunity and resistance to disease based upon analysis of gene expression |
CHICKEN IMAGE | participant | 2.125.000 | 5 |
| 2000-02-01 | Multi-component salmonella livev vaccines: optimising molecular, cellular and immunological parameters to enhance vaccine safety and immunogenicity. |
SALVAC | participant | 1.199.832 | 4 |
| 2000-01-01 | Development of novel vaccines to control infections wlth newly emerging highly pathogenic marek's disease viruses |
MADIVAC | participant | 1.399.971 | 8 |
European Research Ranking